Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Aptuit, Inc. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Aptuit, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thierry Amat has been appointed chief financial officer of Aptuit, Inc. Mr. Amat will oversee the financial and information technology departments. He has more than 20 years of financial management experience in publicly traded companies as well as knowledge of the pharmaceutical and chemical industries. Mr. Amat most recently served as the chief financial officer of Sodexho Inc., a publicly traded food services company. He began his career at Rhone-Poulenc, where he held positions of increasing responsibility, and later worked as vice president and controller for global R&D at Aventis Pharmaceuticals.
    
“Thierry’s global experience and proven leadership will be a significant addition to Aptuit’s management team,” stated Timothy C. Tyson, executive chairman and acting chief executive officer of Aptuit. “His proven successes in all phases of financial management will be a great asset as we move into the next phase of growth. Over the next 12 to 18 months we will make several strategic advances in our efforts to transform customer access to real-time data and truly define the shift toward a paperless business model via programs, such as Clinicopia Connect and Aptuit Fusion.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics